Bo Ni

873 total citations · 1 hit paper
30 papers, 560 citations indexed

About

Bo Ni is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Ni has authored 30 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Ni's work include Gastrointestinal Tumor Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Bo Ni is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Bo Ni collaborates with scholars based in China, Thailand and South Korea. Bo Ni's co-authors include Gang Zhao, Xiang Xia, Enhao Zhao, Shuchang Wang, Fengrong Yu, Chunchao Zhu, Zizhen Zhang, Qing Li, Zizhen Zhang and Qing Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Bo Ni

27 papers receiving 556 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications

2022 149 citations Xiang Xia, Zizhen Zhang et al. Nature Communications profile →

Peers

Bo Ni

IMMUN

ONCOL

PRM

Enhao Zhao China

Katsuharu Saito Japan

Hao Lin China

Yifan Cao China

Αναστασία Κοττόρου Greece

Zi-Hao Qi China

Naita M. Wirsik Germany

Zhifa Cao China

Meng Xie China

Enhao Zhao China

Bo Ni

412 ×1.5

335 ×1.5

196 ×1.2

IMMUN

162 ×1.3

ONCOL

101 ×0.9

PRM

Citations per year, relative to Bo Ni Bo Ni (= 1×) peers Enhao Zhao

Countries citing papers authored by Bo Ni

Since Specialization

Citations

This map shows the geographic impact of Bo Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ni more than expected).

Fields of papers citing papers by Bo Ni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ni. The network helps show where Bo Ni may publish in the future.

Co-authorship network of co-authors of Bo Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ni. A scholar is included among the top collaborators of Bo Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ni. Bo Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ni, Bo, Haoyu Zhang, Yeqian Zhang, et al.. (2025). Clinical study of adebrelimab in combination with apatinib and irinotecan for PD-1 inhibitor-ineffective advanced-stage gastric cancer: study protocol for a single-arm, single-centre, exploratory trial. BMJ Open. 15(6). e089286–e089286.

Ji, Linhua, et al.. (2025). High extracellular matrix stiffness upregulates TNNT1 to awaken dormant tumor cells in liver metastatic niches of gastric cancer. Cellular Oncology. 48(3). 815–834. 1 indexed citations

Ni, Bo, Xueyan Shen, Yeqian Zhang, et al.. (2025). Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer. Translational research. 283. 13–21.

Xie, Yongjie, et al.. (2024). Hypoxic and Acidic Tumor Microenvironment–Driven AVL9 Promotes Chemoresistance of Pancreatic Ductal Adenocarcinoma via the AVL9-IκBα-SKP1 Complex. Gastroenterology. 168(3). 539–555.e5. 1 indexed citations

Li, Qing, et al.. (2024). Circadian system disorder induced by aberrantly activated EFNB2-EPHB2 axis leads to facilitated liver metastasis in gastric cancer. Cellular Oncology. 47(6). 2113–2134. 2 indexed citations

Ni, Bo, Xiang Xia, Linxi Yang, et al.. (2023). A single-center, prospective, single-arm, phase II trial to evaluate the adjuvant efficacy of camrelizumab with docetaxel plus S-1 for stage III (PD-L1⁺/dMMR/EBV⁺) gastric cancer after D2 resection.. Journal of Clinical Oncology. 41(16_suppl). e16089–e16089. 1 indexed citations

Ni, Bo, Xuan He, Yeqian Zhang, et al.. (2023). Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux. Cellular Oncology. 46(2). 315–330. 22 indexed citations

Zhuang, Chun, Xiaoqi Li, Linxi Yang, et al.. (2023). Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors. Frontiers in Oncology. 13. 1151687–1151687. 4 indexed citations

Xia, Xiang, Zizhen Zhang, Chunchao Zhu, et al.. (2022). Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nature Communications. 13(1). 1017–1017. 149 indexed citations breakdown →

10.

Ni, Bo, Qing Li, Chun Zhuang, et al.. (2022). The nerve-tumour regulatory axis GDNF-GFRA1 promotes tumour dormancy, imatinib resistance and local recurrence of gastrointestinal stromal tumours by achieving autophagic flux. Cancer Letters. 535. 215639–215639. 11 indexed citations

11.

Dong, Zhong‐Yi, Bo Ni, Linxi Yang, et al.. (2022). Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm Trial. Frontiers in Surgery. 9. 917352–917352. 4 indexed citations

12.

Wang, Zeyu, Zhong‐Yi Dong, Gang Zhao, Bo Ni, & Zizhen Zhang. (2022). Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study. Journal of Gastrointestinal Oncology. 13(3). 1340–1350. 5 indexed citations

13.

Li, Rongkun, Lili Zhu, Xiaoxin Zhang, et al.. (2021). Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness. Cell Death and Disease. 12(12). 1106–1106. 27 indexed citations

14.

Zhuang, Chun, Bo Ni, Zizhen Zhang, et al.. (2021). Low Distribution of TIM-3+ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors. Journal of Immunology Research. 2021. 1–10. 4 indexed citations

15.

Zhang, Yeqian, Fengrong Yu, Bo Ni, et al.. (2021). The RNA-Binding Protein DDX18 Promotes Gastric Cancer by Affecting the Maturation of MicroRNA-21. Frontiers in Oncology. 10. 598238–598238. 15 indexed citations

16.

Zhou, Yang, Fei Liu, Qinyang Xu, et al.. (2020). Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. Oncogene. 39(34). 5633–5648. 27 indexed citations

17.

Shen, Yanying, Xinli Ma, Linxi Yang, et al.. (2020). Clinicopathologic characteristics, diagnostic clues, and prognoses of patients with multiple sporadic gastrointestinal stromal tumors: a case series and review of the literature. Diagnostic Pathology. 15(1). 56–56. 4 indexed citations

18.

Xia, Xiang, Shuchang Wang, Bo Ni, et al.. (2020). Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop. Oncogene. 39(39). 6231–6244. 101 indexed citations

19.

Li, Qing, Chunchao Zhu, Bo Ni, et al.. (2019). Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts. EBioMedicine. 49. 157–171. 76 indexed citations

20.

Xu, Danhua, Qing Li, Hao Hu, et al.. (2018). Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 308–308. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact